Varicella Health Article

References

1 Weller TH, Witton HM, Bell EJ. The etiologic agents of varicella and herpes zoster; isolation, propagation, and cultural characteristics in vitro J Exp Med 108 1958 843 868
2 Arvin AM. Varicella-zoster virus Clin Microbiol Rev 9 1996 361 381
3 Gershon AA, Takahashi M, Seward JF. Varicella vaccine Plotkin S Orenstein W Vaccines 4th edn. 2004 WB Saunders Philadelphia 783 823
4 Hope-Simpson RE. Infectiousness of communicable diseases in the household (measles, chickenpox and mumps) Lancet 2 1952 549 554
5 Wharton M. The epidemiology of varicella-zoster virus infections Infect Dis Clin North Am 10 1996 571 581
6 Aebi C, Fischer K, Gorgievski M, Matter L, Muhlemann K. Age-specific seroprevalence to varicella-zoster virus: study in Swiss children and analysis of European data Vaccine 19 2001 3097 3103
7 Brisson M, Edmunds WJ, Law B. Epidemiology of varicella zoster virus infection in Canada and the United Kingdom Epidemiol Infect 127 2001 305 314
8 Heininger U, Braun-Fahrlander C, Desgrandchamps D. Seroprevalence of varicella-zoster virus immunoglobulin G antibodies in Swiss adolescents and risk factor analysis for seronegativity Pediatr Infect Dis J 20 2001 775 778
9 Wutzler P, Farber I, Wagenpfeil S. Seroprevalence of varicella-zoster in the German population Vaccine 20 2002 121 124
10 Hunt SM, McKenna SP. Childhood chickenpox: its impact on child and family Fam Pract 10 1993 19 22
11 Jaeggi A, Zurbruegg RP, Aebi C. Complications of varicella in a defined central European population Arch Dis Child 79 1998 472 477
12 Laupland KB, Davies HD, Low DE, Schwartz B, Green K, McGeer A. Invasive group A streptococcal disease in children and association with varicella-zoster virus infection. Ontario Group A Streptococcal Study Group Pediatrics 105 2000 E60
13 Meyer PA, Seward JF, Jumaan AO, Wharton M. Varicella mortality: trends before vaccine licensure in the United States, 1970–1994 J Infect Dis 182 2000 383 390
14 Bonhoeffer J, Baer G, Muehleisen B. Prospective surveillance of hospitalisations associated with varicella-zoster virus infections in children and adolescents Eur J Pediatr 164 2005 366 370
15 Law B, MacDonald N, Halperin S. The Immunization Monitoring Program Active (IMPACT) prospective five year study of Canadian children hospitalised for chickenpox or an associated complication Pediatr Infect Dis J 19 2000 1053 1059
16 Ross AH. Modification of chickenpox in family contacts by administration of gamma globulin N Engl J Med 267 1962 369 376
17 Seward JF, Zhang JX, Maupin TJ, Mascola L, Jumaan AO. Contagiousness of varicella in vaccinated cases, a household contact study JAMA 292 2004 704 708
18 Asano Y, Nakayama H, Yazaki T. Protection against varicella in family contacts by immediate inoculation with live varicella vaccine Pediatrics 59 1977 3 7
19 Lieu T, Cochi S, Black S. Cost-effectiveness of a routine varicella vaccination program for U.S. children JAMA 271 1994 375 381
20 Coudeville L, Paree F, Lebrun T, Sailly J. The value of varicella vaccination in healthy children: cost-benefit analysis of the situation in France Vaccine 17 1999 142 151
21 Law B, Fitzsimon C, Ford-Jones L. Cost of chickenpox in Canada: Part 1. Cost of uncomplicated cases Pediatrics 104 1999 1 6
22 Somekh E, Dalal I, Shohat T, Ginsberg GM, Romano O. The burden of uncomplicated cases of chickenpox in Israel J Infect 45 2002 233 236
23 Lungu O, Annunziato PW, Gershon A. Reactivated and latent varicella-zoster virus in human dorsal root ganglia Proc Natl Acad Sci USA 92 1995 10980 10984
24 Hope-Simpson HE. The nature of herpes zoster: A long term study and a new hypothesis Proc R Soc Med 58 1965 9 20
25 Weller TH, Witton HM, Bell EJ. The etiologic agents of varicella and herpes zoster; isolation, propagation, and cultural characteristics in vitro J Exp Med 108 1958 843 868
26 Katz J, Cooper EM, Walther RR, Sweeney EW, Dworkin RH. Acute pain in herpes zoster and its impact on health-related quality of life Clin Infect Dis 39 2004 342 348
27 Oxman MN, Levin MJ, Johnson GR. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults N Engl J Med 352 2005 2271 2284
28 US Food and Drug Administration. Product Approval Information—Licensing Action May 26, 2006 US FDA Maryland, USA
29 Padovan D, Cantrell CA. Varicella-like herpesvirus infections of nonhuman primates Lab Anim Sci 36 1986 7 13
30 Davison AJ, Scott JE. The complete DNA sequence of varicella-zoster virus J Gen Virol 67 1986 1759 1816
31 Cohrs RJ, Hurley MP, Gilden DH. Array analysis of viral gene transcription during lytic infection of cells in tissue culture with varicella-zoster virus J Virol 77 2003 11718 11732
32 Davison AJ. Varicella-zoster virus. The fourteenth Fleming lecture J Gen Virol 72 1991 475 486
33 Grose C. Glycoproteins encoded by varicella-zoster virus: biosynthesis, phosphorylation, and intracellular trafficking Annu Rev Microbiol 44 1990 59 80
34 Mettenleiter TC. Budding events in herpesvirus morphogenesis Virus Res 106 2004 167 180
35 Martin JH, Dohner DE, Wellinghoff WJ, Gelb LD. Restriction endonuclease analysis of varicella-zoster vaccine virus and wild-type DNAs J Med Virol 9 1982 69 76
36 Barrett-Muir W, Scott FT, Aaby P. Genetic variation of varicella-zoster virus: evidence for geographical separation of strains J Med Virol 70 2003 S42 S47
37 Loparev VN, Gonzalez A, Deleon-Carnes M. Global identification of three major genotypes of varicella-zoster virus: longitudinal clustering and strategies for genotyping J Virol 78 2004 8349 8358
38 Gomi Y, Sunamachi H, Mori Y, Nagaike K, Takahashi M, Yamanishi K. Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus J Virol 76 2002 11447 11459
39 Kido S, Ozaki T, Asada H. Detection of varicella-zoster virus (VZV) DNA in clinical samples from patients with VZV by the polymerase chain reaction J Clin Microbiol 29 1991 76 79
40 Koropchak CM, Graham G, Palmer J. Investigation of varicella-zoster virus infection by polymerase chain reaction in the immunocompetent host with acute varicella J Infect Dis 163 1991 1016 1022
41 Sawyer MH, Wu YN, Chamberlin CJ. Detection of varicella-zoster virus DNA in the oropharynx and blood of patients with varicella J Infect Dis 166 1992 885 888
42 Suzuki K, Yoshikawa T, Ihira M, Ohashi M, Suga S, Asano Y. Spread of varicella-zoster virus DNA to the environment from varicella patients who were treated with oral acyclovir Pediatr Int 45 2003 458 460
43 Duus KM, Grose C. Multiple regulatory effects of varicella-zoster virus (VZV) gL on trafficking patterns and fusogenic properties of VZV gH J Virol 70 1996 8961 8971
44 Grose C, Edmond BJ, Friedrichs WE. Immunogenic glycoproteins of laboratory and vaccine strains of varicella-zoster virus Infect Immun 31 1981 1044 1053
45 Giller RH, Winistorfer S, Grose C. Cellular and humoral immunity to varicella zoster virus glycoproteins in immune and susceptible human subjects J Infect Dis 160 1989 919 928
46 Bergen RE, Sharp M, Sanchez A, Judd AK, Arvin AM. Human T cells recognize multiple epitopes of an immediate early/tegument protein (IE62) and glycoprotein I of varicella zoster virus Viral Immunol 4 1991 51 66
47 Dueland AN, Martin JR, Devlin ME. Acute simian varicella infection. Clinical, laboratory, pathologic, and virologic features Lab Invest 66 1992 762 773
48 Verstraelen H, Vanzieleghem B, Defoort P, Vanhaesebrouck P, Temmerman M. Prenatal ultrasound and magnetic resonance imaging in fetal varicella syndrome: correlation with pathology findings Prenat Diagn 23 2003 705 709
49 Tsolia M, Gershon AA, Steinberg SP, Gelb L. Live attenuated varicella vaccine: evidence that the virus is attenuated and the importance of skin lesions in transmission of varicella-zoster virus. National institute of allergy and infectious diseases varicella vaccine collaborative study group J Pediatr 116 1990 184 189
50 Chen JJ, Zhu Z, Gershon AA, Gershon MD. Mannose 6-phosphate receptor dependence of varicella zoster virus infection in vitro and in the epidermis during varicella and zoster Cell 119 2004 915 926
51 Shanley J, Myers M, Edmond B, Steele R. Enzyme-linked immunosorbent assay for detection of antibody to varicella-zoster virus J Clin Microbiol 15 1982 208 211
52 van Loon AM, van der Logt JT, Heessen FW, Heeren MC, Zoll J. Antibody-capture enzyme-linked immunosorbent assays that use enzyme-labelled antigen for detection of virus-specific immunoglobulin M, A and G in patients with varicella or herpes zoster Epidemiol Infect 108 1992 165 174
53 Sauerbrei A, Farber I, Brandstadt A, Schacke M, Wutzler P. Immunofluorescence test for sensitive detection of varicella-zoster virus-specific IgG: an alternative to fluorescent antibody to membrane antigen test J Virol Methods 119 2004 25 30
54 Smith JG, Liu X, Kaufhold RM, Clair J, Caulfield MJ. Development and validation of a gamma interferon ELISPOT assay for quantitation of cellular immune responses to varicella-zoster virus Clin Diagn Lab Immunol 8 2001 871 879
55 Etzioni A, Eidenschenk C, Katz R, Beck R, Casanova JL, Pollack S. Fatal varicella associated with selective natural killer cell deficiency J Pediatr 146 2005 423 425
56 Feldman S, Hughes WT, Daniel CB. Varicella in children with cancer: Seventy-seven cases Pediatrics 56 1975 388 397
57 Guess HA, Broughton DD, Melton LJ, Kurland LT. Epidemiology of herpes zoster in children and adolescents: a population-based study Pediatrics 76 1985 512 517
58 Preblud SR. Varicella: complications and costs Pediatrics 76 suppl 1986 728 735
59 Terada K, Kawano S, Hiraga Y, Morita T. Reactivation of chickenpox contracted in infancy Arch Dis Child 73 1995 162 163
60 Chen SH, Liang DC. Intravenous immunoglobulin prophylaxis in children with acute leukemia following exposure to varicella Pediatr Hematol Oncol 9 1992 347 351
61 Junker AK, Tilley P. Varicella-zoster virus antibody avidity and IgG-subclass patterns in children with recurrent chickenpox J Med Virol 43 1994 119 124
62 Terada K, Kawano S, Shimada Y, Yagi Y, Kataoka N. Recurrent chickenpox after natural infection Pediatr Infect Dis J 15 1996 179 181
63 Lee BW. Review of varicella zoster seroepidemiology in India and Southeast Asia Trop Med Int Health 3 1998 886 890
64 Seward J, Galil K, Wharton M. Epidemiology of varicella Arvin A Gershon A Varicella-zoster virus 2000 Cambridge University Press Cambridge 187 205
65 Kilgore PE, Kruszon-Moran D, Seward JF. Varicella in Americans from NHANES III: implications for control through routine immunization J Med Virol 70 2003 111 118
66 Kudesia G, Partridge S, Farrington CP, Soltanpoor N. Changes in age related seroprevalence of antibody to varicella zoster virus: impact on vaccine strategy J Clin Pathol 55 2002 154 155
67 Mandal BK, Mukherjee PP, Murphy C. Adult susceptibility to varicella in the tropics is a rural phenomenon due to lack of previous exposure J Infect Dis 178 1998 52 54
68 Ooi PL, Goh KT, Doraisingham S, Ling AE. Prevalence of varicella-zoster virus infection in Singapore Southeast Asian J Trop Med Public Health 23 1992 22 25
69 Bramley JC, Jones IG. Epidemiology of chickenpox in Scotland: 1981 to 1998 Commun Dis Public Health 3 2000 82 87
70 Deguen S, Chau NP, Flahault A. Epidemiology of chickenpox in France (1991–1995) J Epidemiol Community Health 52 1998 46 49
71 Iyun F. Chickenpox occurrence in Ibadan City, a geographical perspective Geogr Med 14 1986 73 96
72 Tobias M, Reid S, Lennon D. Chickenpox immunization in New Zealand N Z Med J 111 1998 274 281
73 Guess HA, Broughton DD, Melton LJ. Population-based studies of varicella complications Pediatrics 78 1986 723 727
74 Fairley CK, Miller E. Varicella-zoster virus epidemiology—A changing scene? J Infect Dis 174 1996 314 319
75 Finger R, Hughes JP, Meade BJ. Age-specific incidence of chickenpox Pub Health Reps 190 1994 750 755
76 Gabutti G, Penna C, Rossi M. The seroepidemiology of varicella in Italy Epidemiol Infect 126 2001 433 440
77 Ross AM, Fleming DM. Chickenpox increasingly affects preschool children Commun Dis Public Health 3 2000 213 215
78 Socan M, Kraigher A, Pahor L. Epidemiology of varicella in Slovenia over a 20-year period (1979–1998) Epidemiol Infect 126 2001 279 283
79 Yawn BP, Yawn RA, Lydick E. Community impact of childhood varicella infections J Pediatr 130 1997 759 765
80 Hurwitz ES, Gunn WJ, Pinsky PF. Risk of respiratory illness associated with day-care attendan a nationwide study Pediatrics 87 1991 62 69
81 Jerant AF, DeGaetano JS, Epperly TD. Varicella susceptibility and vaccination strategies in young adults J Am Board Fam Pract 11 1998 296 306
82 Enders G, Miller E. Epidemiology and herpes zoster in pregnancy and the newborn Arvin A Gershon A Varicella Zoster Virus: Virology and Clinical Management 2000 Cambridge University Press Cambridge, UK 317 350
83 Boelle PY, Hanslik T. Varicella in non-immune persons: incidence, hospitalization and mortality rates Epidemiol Infect 129 2002 599 606
84 Chant KG, Sullivan EA, Burgess MA. Varicella-zoster virus infection in Australia Aust N Z J Public Health 22 1998 413 418
85 Rawson H, Crampin A, Noah N. Deaths from chickenpox in England and Wales 1995–97: analysis of routine mortality date BMJ 323 2001 1091 1093
86 Galil K, Brown C, Lin F, Seward J. Hospitalizations for varicella in the United States, 1988 to 1999 Pediatr Infect Dis J 21 2002 931 935
87 Ratner AJ. Varicella-related hospitalizations in the vaccine era Pediatr Infect Dis J 21 2002 927 930
88 Poulsen A, Cabral F, Nielsen J. Varicella zoster in Guinea–Bissau: intensity of exposure and severity of infection Pediatr Infect Dis J 24 2005 102 107
89 Welgama U, Wickramasinghe C, Perera J. Varicella-zoster virus infection in the Infectious Diseases Hospital, Sri Lanka Ceylon Med J 48 2003 119 121
90 Leung AK, Kao CP, Sauve RS. Scarring resulting from chickenpox Pediatr Dermatol 18 2001 378 380
91 Watson BM, Piercy SA, Plotkin SA, Starr SE. Modified chickenpox in children immunized with the Oka/Merck varicella vaccine Pediatrics 91 1993 17 22
92 Bernstein HH, Rothstein EP, Watson BM. Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka/Merck varicella vaccine Pediatrics 92 1993 833 837
93 Galil K, Lee B, Strine T. Outbreak of varicella at a day-care center despite vaccination N Engl J Med 347 2002 1909 1915
94 Tyrrell GJ, Lovgren M, Kress B, Grimsrud K. Varicella-associated invasive group a streptococcal disease in Alberta, Canada 2000–2002 Clin Infect Dis 40 2005 1055 1057
95 Askalan R, Laughlin S, Mayank S. Chickenpox and stroke in childhood: a study of frequency and causation Stroke 32 2001 1257 1262
96 Choo PW, Donahue JG, Manson JE, Platt R. The epidemiology of varicella and its complications J Infect Dis 172 1995 706 712
97 Harger JH, Ernest JM, Thurnau GR. Frequency of congenital varicella syndrome in a prospective cohort of 347 pregnant women Obstet Gynecol 100 2002 260 265
98 Enders G, Miller E, Cradock-Watson J, Bolley I, Ridehalgh M. Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases Lancet 343 1994 1548 1551
99 Tan MP, Koren G. Chickenpox in pregnancy: revisited Reprod Toxicol 21 2006 410 420
100 LaForet EG, Lynch LL. Multiple congenital defects following maternal varicella N Engl Med J 236 1947 534 537
101 Miller E, Cradock-Watson JE, Ridehalgh MK. Outcome in newborn babies given anti-varicella-zoster immunoglobulin after perinatal maternal infection with varicella-zoster virus Lancet 2 1989 371 373
102 Gershon A. Varicella in mother and infant: problems old and new Krugman S Gershon A Infections of the Fetus and the Newborn Infant: Progress in Clinical and Biological Research 1975 Alan R Liss New York 79 95
103 Longley J, Demar L, Feinstein RP, Miller RL, Silvers DN. Clinical and histologic features of pityriasis lichenoides et varioliformis acuta in children Arch Dermatol 123 1987 1335 1339
104 Fenner F, Henderson DA, Arita I, Jezek Z, Ladnyi ID. Smallpox and its eradication 1988 WHO Geneva
105 Jezek Z, Basu RN, Arya ZS. Fever with rash surveillance in India Indian J Public Health 22 1978 120 126
106 Seward JF, Galil K, Damon I. Development and experience with an algorithm to evaluate smallpox cases in the United States, 2002–2004 Clin Infect Dis 39 2004 1477 1483
107 Girisch M, Fartasch M, Schroth M. Kongenitale langerhans-zellen-histiozytose unter dem klinischen bild einer varizelleninfektion Klin Padiatr 211 1999 403 405
108 Loparev VN, Argaw T, Krause P, Takayama M, Schmid S. Improved identification and differentiation of varicella-zoster virus (VZV) wild type strains and an attenuated varicella vaccine strain using a VZV open reading frame 62-based PCR J Clin Microbiol 38 2000 3156 3160
109 Argaw T, Cohen JI, Klutch M. Nucleotide sequences that distinguish Oka vaccine from parental Oka and other varicella-zoster virus isolates J Infect Dis 181 2000 1153 1157
110 Quinlivan M, Gershon AA, Steinberg SP, Breuer J. An evaluation of single nucleotide polymorphisms used to differentiate vaccine and wild type strains of varicella-zoster virus J Med Virol 75 2005 174 180
111 Loparev VN, McCaustland K, Holloway BP, Krause PR, Takayama M, Schmid DS. Rapid genotyping of varicella-zoster virus vaccine and wild-type strains with fluorophore-labeled hybridization probes J Clin Microbiol 38 2000 4315 4319
112 Krah DL. Assays for antibodies to varicella-zoster virus Infect Dis Clin North Am 10 1996 507 527
113 Shiraki K, Okuno T, Yamanishi K. Polypeptides of varicella-zoster virus (VZV) and immunological relationship of VZV and herpes simplex virus (HSV) J Gen Virol 61 1982 255 269
114 Oladepo DK, Klapper PE, Percival D, Vallely PJ. Serological diagnosis of varicella-zoster virus in sera with antibody-capture enzyme-linked immunosorbent assay of IgM J Virol Meth 84 2000 169 173
115 Williams V, Gershon A, Brunell PA. Serologic response to varicella-zoster membrane antigens measured by direct immunofluorescence J Infect Dis 130 1974 669 672
116 Junker AK, Angus E, Thomas EE. Recurrent varicella-zoster virus infections in apparently immunocompetent children Pediatr Infect Dis J 10 1991 569 575
117 Martin KA, Junker AK, Thomas EE, Van Allen MI, Friedman JM. Occurrence of chickenpox during pregnancy in women seropositive for varicella-zoster virus J Infect Dis 170 1994 991 995
118 Ampofo K, Saiman L, LaRussa P, Steinberg S, Annunziato P, Gershon A. Persistence of immunity to live attenuated varicella vaccine in healthy adults Clin Infect Dis 34 2002 774 779
119 Chan IS, Li S, Matthews H. Use of statistical models for evaluating antibody response as a correlate of protection against varicella Stat Med 21 2002 3411 3430
120 Li S, Chan IS, Matthews H. Inverse relationship between six week postvaccination varicella antibody response to vaccine and likelihood of long term breakthrough infection Pediatr Infect Dis J 21 2002 337 342
121 Wasmuth EH, Miller WJ. Sensitive enzyme-linked immunosorbent assay for antibody to varicella-zoster virus using purified VZV glycoprotein antigen J Med Virol 32 1990 189 193
122 Kuter B, Matthews H, Shinefield H. Ten year follow-up of healthy children who received one or two injections of varicella vaccine Pediatr Infect Dis J 23 2004 132 227
123 Shehab Z, Brunell A. Enzyme-linked immunosorbent assay for susceptibility to varicella J Infect Dis 148 1983 472 476
124 Starko KM, Ray CG, Dominguez LB, Stromberg WL, Woodall DF. Reye's syndrome and salicylate use Pediatrics 66 1980 859 864
125 Lesko SM, O'Brien KL, Schwartz B, Vezina R, Mitchell AA. Invasive group A streptococcal infection and nonsteroidal antiinflammatory drug use among children with primary varicella Pediatrics 107 2001 1108 1115
126 Zerr DM, Alexander ER, Duchin JS, Koutsky LA, Rubens CE. A case-control study of necrotizing fasciitis during primary varicella Pediatrics 103 1999 783 790
127 Shepp DH, Dandliker PS, Meyers JD. Treatment of varicella-zoster virus infection in severely immunocompromised patients. A randomized comparison of acyclovir and vidarabine N Engl J Med 314 1986 208 212
128 Dunkle LM, Arvin AM, Whitley RJ. A controlled trial of acyclovir for chickenpox in normal children N Engl J Med 325 1991 1539 1544
129 American Academy of Pediatrics Committee on Infectious Diseases. The use of oral acyclovir in otherwise healthy children with varicella Pediatrics 91 1993 674 676
130 Enright AM, Prober C. Antiviral therapy in children with varicella zoster virus and herpes simplex virus infections Herpes 10 2003 32 37
131 Takahashi M, Okuno Y, Otsuka T. Development of a live attenuated varicella vaccine Biken J 18 1975 25 33
132 Centers for Disease Control and Prevention. Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Morb Mortal Wkly Rep 45 1996 1 36
133 Centers for Disease Control. Prevention of varicella MMWR Morb Mortal Wkly Rep 48 1999 1 6
134 Shinefield H, Black S, Digilio L. Evaluation of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children Pediatr Infect Dis J 24 2005 665 669
135 Knuf M, Habermehl P, Zepp F. Immunogenicity and safety of two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children Pediatr Infect Dis J 25 2006 12 18
136 Weibel R, Neff BJ, Kuter BJ. Live attenuated varicella virus vaccine: efficacy trial in healthy children N Engl J Med 310 1984 1409 1415
137 Varis T, Vesikari T. Efficacy of high-titer live attenuated varicella vaccine in healthy young children J Infect Dis 174 suppl 3 1996 330 334
138 Izurieta HS, Strebel PM, Blake PA. Postlicensure effectiveness of varicella vaccine during an outbreak in a child care center JAMA 278 1997 1495 1499
139 Buchholz U, Moolenaar R, Peterson C, Mascola L. Varicella outbreaks after vaccine licensure: sholuld they make you chicken? Pediatrics 104 1999 561 563
140 Clements D, Moreira SP, Coplan P, Bland C, Walter E. Postlicensure study of varicella vaccine effectiveness in a day-care setting Ped Infect Dis J 18 1999 1047 1050
141 Vazquez M, LaRussa P, Gershon A, Steinberg S, Freudigman K, Shapiro E. The effectiveness of the varicella vaccine in clinical practice N Engl J Med 344 2001 955 960
142 Dworkin MS, Jennings CE, Roth-Thomas J. An Outbreak of Varicella among children attending preschool and elementary school in Illinois Clin Infect Dis 35 2002 102 104
143 Galil K, Fair E, Mountcastle N, Britz P, Seward JF. Younger age at vaccination may increase risk of varicella vaccine failure J Infect Dis 186 2002 102 105
144 Centers for Disease Control and Prevention. Outbreak of varicella among vaccinated children—Michigan, 2003 MMWR Morb Mortal Wkly Rep 53 2004 389 392
145 Vazquez M, LaRussa PS, Gershon AA. Effectiveness over time of varicella vaccine JAMA 291 2004 851 855
146 Tugwell BD, Lee LE, Gillette H, Lorber EM, Hedberg K, Cieslak PR. Chickenpox outbreak in a highly vaccinated school population Pediatrics 113 2004 455 459
147 Passwell JH, Hemo B, Levi Y, Ramon R, Friedman N, Lerner-Geva L. Use of a computerized database to study the effectiveness of an attenuated varicella vaccine Pediatr Infect Dis J 23 2004 221 226
148 Lee BR, Feaver SL, Miller CA, Hedberg CW, Ehresmann KR. An elementary school outbreak of varicella attributed to vaccine failure: policy implications J Infect Dis 190 2004 477 483
149 Marin M, Nguyen HQ, Keen J. Importance of catch-up vaccination: experience from a varicella outbreak, Maine, 2002–2003 Pediatrics 115 2005 900 905
150 Haddad MB, Hill MB, Pavia AT. Vaccine effectiveness during a varicella outbreak among schoolchildren: Utah, 2002–2003 Pediatrics 115 2005 1488 1493
151 Miron D, Lavi I, Kitov R, Hendler A. Vaccine effectiveness and severity of varicella among previously vaccinated children during outbreaks in day-care centers with low vaccination coverage Pediatr Infect Dis J 24 2005 233 236
152 Sheffer R, Segal D, Rahamani S. Effectiveness of the Oka/GSK attenuated varicella vaccine for the prevention of chickenpox in clinical practice in Israel Pediatr Infect Dis J 24 2005 434 447
153 Lopez AS, Guris D, Zimmerman L. One dose of varicella vaccine does not prevent school outbreaks—is it time for a second dose? Pediatrics 117 2006 1070 1077
154 Arvin AA. Varicella vaccine: genesis, efficacy and attenuation Virology 284 2001 153 158
155 Vazquez M. Varicella infections and varicella vaccine in the 21st century Pediatr Infect Dis J 23 2004 871 872
156 Sharrar RG, LaRussa P, Galea SA. The postmarketing safety profile of varicella vaccine Vaccine 19 2000 916 923
157 Wise RP, Salive ME, Braun MM. Postlicensure safety surveillance for varicella vaccine JAMA 284 2000 1271 1279
158 Black S, Shinefield H, Ray P. Postmarketing evaluation of the safety and effectiveness of varicella vaccine Pediatr Infect Dis J 18 1999 1041 1046
159 LaRussa P, Steinberg S, Maurice F, Gershon A. Transmission of vaccine strain varicella-zoster virus from a healthy adult with vaccine-associated rash to susceptible household contacts J Infect Dis 176 1997 1072 1075
160 Kramer JM, LaRussa P, Tsai WC. Disseminated vaccine strain varicella as the acquired immunodeficiency syndrome-defining illness in a previously undiagnosed child Pediatrics 108 2001 E39
161 Levy O, Orange JS, Hibberd P. Disseminated varicella infection due to the vaccine strain of varicella-zoster virus, in a patient with a novel deficiency in natural killer T cells J Infect Dis 188 2003 948 953
162 Gershon AA. Varicella vaccine: rare serious problems—but the benefits still outweigh the risks J Infect Dis 188 2003 945 947
163 Sunaga Y, Hikima A, Ostuka T, Morikawa A. Acute cerebellar ataxia with abnormal MRI lesions after varicella vaccination Pediatr Neurol 13 1995 340 342
164 Wirrell E, Hill MD, Jadavji T, Kirton A, Barlow K. Stroke after varicella vaccination J Pediatr 145 2004 845 847
165 Hardy I, Gershon AA, Steinberg SP, LaRussa P. The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia N Engl J Med 325 1991 1545 1550
166 Salisbury D, Begg N. Immunisation Against Infectious Disease 1996–“The Green Book” 1996 UK Department of Health London
167 Centers for Disease Control. A new product (VariZIG) for postexposure prophylaxis of varicella available under an investigational new drug application expanded access protocol MMWR Morb Mortal Wkly Rep 55 2006 209 210
168 Lin TY, Huang YC, Ning HC, Hsueh C. Oral acyclovir prophylaxis of varicella after intimate contact Pediatr Infect Dis J 16 1997 1162 1165
169 Kumagai T, Kamada M, Igarashi C. Varicella-zoster virus-specific cellular immunity in subjects given acyclovir after household chickenpox exposure J Infect Dis 180 1999 834 837
170 Asano Y, Yoshikawa T, Suga S. Postexposure prophylaxis of varicella in family contact by oral acyclovir Pediatrics 92 1993 219 222
171 Arbeter AM, Starr SE, Preblud S. Varicella vaccine trials in healthy children: a summary of comparative follow-up studies Am J Dis Child 138 1984 434 438
172 Salzman MB, Garcia C. Postexposure varicella vaccination in siblings of children with active varicella Pediatr Infect Dis J 17 1998 256 257
173 Hanslik T, Boelle PY, Schwarzinger M. Varicella in French adolescents and adults: individual risk assessment and cost-effectiveness of routine vaccination Vaccine 21 2003 3614 3622
174 Carapetis JR, Russell DM, Curtis N. The burden and cost of hospitalised varicella and zoster in Australian children Vaccine 23 2004 755 761
175 World Health Organization. Varicella vaccines. WHO position paper Wkly Epidemiol Rec 73 1998 241 248
176 Santos AM, Ono E, Weckx LY, Coutinho AP, de Moraes-Pinto MI. Varicella zoster antibodies in healthcare workers from two neonatal units in Sao Paulo, Brazil—assessment of a staff varicella policy J Hosp Infect 58 2004 92 93
177 Centers for Disease Control and Prevention. National, state, and urban area vaccination coverage among children aged 19–35 months—United States, 2004 MMWR Morb Mortal Wkly Rep 54 2005 717 721
178 Brisson M, Edmunds WJ, Gay NJ, Law B, De Serres G. Modelling the impact of immunization on the epidemiology of varicella zoster virus Epidemiol Infect 125 2000 651 669
179 Thomas SL, Wheeler JG, Hall AJ. Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study Lancet 360 2002 678 682
180 Brisson M, Edmunds WJ, Law B. Epidemiology of varicella zoster virus infection in Canada and the United Kingdom Epidemiol Infect 127 2001 305 314
181 Centers for Disease Control and Prevention. Decline in Annual Incidence of Varicella–selected states, 1990–2001 MMWR Morb Mortal Wkly Rep 52 2003 884 885
182 Yih WK, Brooks DR, Lett SM. The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998–2003 BMC Public Health 5 2005 68
183 Mullooly JP, Riedlinger K, Chun C, Weinmann S, Houston H. Incidence of herpes zoster, 1997–2002 Epidemiol Infect 133 2005 245 253
184 Leung J, Molinari N, Harpaz R. Trends in the incidence of herpes zoster using a national insurance database: United States, 1993–2003. 43rd annual meeting of Infectious Diseases Society of America (IDSA); San Francisco, CA. USA; Oct 69, 2005; Abstract 928.
185 Jumaan AO, Yu O, Jackson LA, Bohlke K, Galil K, Seward JF. Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992–2002 J Infect Dis 191 2005 2002 2007
186 Seward JF, Watson BM, Peterson CL. Varicella disease after introduction of varicella vaccine in the United States, 1995–2000 JAMA 287 2002 606 611
187 Davis MM, Patel MS, Gebremariam A. Decline in varicella-related hospitalizations and expenditures for children and adults after introduction of varicella vaccine in the United States Pediatrics 114 2004 786 792
188 Nguyen H, Jumaan AO, Seward JF. Decline in mortality due to varicella after implementation of varicella vaccination in the United States N Engl J Med 352 2005 450 458
189 Zhou F, Harpaz R, Jumaan AO. Impact of varicella vaccination on health care utilization JAMA 294 2005 797 802
190 Galil K, Pletcher MJ, Wallace BJ. Tracking varicella deaths: accuracy and completeness of death certificates and hospital discharge records, New York State, 1989–1995 Am J Public Health 92 2002 1248 1250
191 Gershon AA. Varicella vaccine–are two doses better than one? N Engl J Med 347 2002 1962 1963
192 Thiry N, Beutels P, Tancredi F. An economic evaluation of varicella vaccination in Italian adolescents Vaccine 22 2004 3546 3562
193 Gidding HF, Brisson M, Macintyre CR, Burgess MA. Modelling the impact of vaccination on the epidemiology of varicella zoster virus in Australia Aust N Z J Public Health 29 2005 544 551
194 Advisory Committee on Immunization Practices. Provisional Recommendations for Prevention of Varicella http://www.cdc.gov/nip/vaccine/varicella/varicella_acip_recs_prov_june_2006.pdf